Loading…

Preparation, analysis and biodistribution in mice of iodine-123 labelled derivatives of hypericin

The synthesis of iodine‐123 labelled mono‐ and di‐iodo derivatives of hypericin, an hydroxylated phenanthroperylenequinone which is used for photodynamic therapy and has been shown to accumulate in several tumour types, is reported. Labelling was performed by electrophilic substitution on hypericin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of labelled compounds & radiopharmaceuticals 2004-03, Vol.47 (3), p.191-198
Main Authors: Bormans, Guy, Huyghe, Dieter, Christiaen, Annemie, Verbeke, Kristin, de Groot, Tjibbe, Vanbilloen, Hubert, de Witte, Peter, Verbruggen, Alfons
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The synthesis of iodine‐123 labelled mono‐ and di‐iodo derivatives of hypericin, an hydroxylated phenanthroperylenequinone which is used for photodynamic therapy and has been shown to accumulate in several tumour types, is reported. Labelling was performed by electrophilic substitution on hypericin or iodohypericin with [123I]iodide in the presence of peracetic acid and provided both mono‐[123I]iodohypericin and di‐[123I]iodohypericin in good radiochemical yields (>80%). Mono‐[123I]iodohypericin was obtained with a high specific activity (925 GBq/μmol) whereas di‐[123I]iodohypericin was obtained in low specific activity (4 GBq/μmol) due to deiodination and subsequent iodination of iodohypericin which occurred during the labelling reaction. Biodistribution studies in mice showed a slow blood clearance and extensive hepatobiliary clearance as well as faecal excretion for both compounds. They will be further evaluated with regard to their tumor seeking properties. Copyright © 2004 John Wiley & Sons, Ltd.
ISSN:0362-4803
1099-1344
DOI:10.1002/jlcr.812